Preimplantation Genetic Testing: Recent Advances in Reproductive Medicine

Preimplantation genetic testing (PGT) is now well established as a valuable treatment option for patients wishing to start or continue a family, for a range of indications from advanced maternal age to high risk of transmitting inherited disease. This text brings together contemporary thinking from international opinion leaders and will be an invaluable guide for practitioners in Reproductive Medicine wishing to keep pace with the latest developments and clinical data.

Darren K Griffin, PhD, DSc, FRSA, FRSB, FRCPath, is Professor of Genetics at the School of Biosciences, University of Kent, Canterbury, UK, President of the International Chromosome and Genome Society, and Director of the Centre for Interdisciplinary Studies of Reproduction. Gary Harton, PhD, is Global Director of Market Development PGD for Perkin-Elmer Inc., Waltham, MA, teacher at Eastern Virginia Medical School, Norfolk, VA, and at Bryant University, Smithfield, RI, USA: he has worked for over 20 years in both laboratory and clinical management in the IVF field and has served on a number of international committees including the ESHRE PGD Consortium and the UK Steering Committee for External Quality Assessment.